Open AccessNovel lumen‐apposing metal stent for the drainage of pancreatic fluid collections: An Italian multicentre experience
Author(s) -
Petrone Maria Chiara,
Archibugi Livia,
Forti Edoardo,
Conigliaro Rita,
Di Mitri Roberto,
Tarantino Ilaria,
Fabbri Carlo,
Larghi Alberto,
Testoni Sabrina Gloria Giulia,
Mutignani Massimiliano,
Arcidiacono Paolo Giorgio
Publication year - 2018
Publication title -
ueg journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.667
H-Index - 35
eISSN - 2050-6414
pISSN - 2050-6406
DOI - 10.1177/2050640618785078
Subject(s) - medicine , stent , pancreatic pseudocyst , lumen (anatomy) , drainage , adverse effect , surgery , occlusion , endoscopic ultrasound , radiology , pancreatitis , ecology , biology
Background Endoscopic ultrasound (EUS)‐guided drainage is the procedure of choice for pancreatic fluid collection (PFC) management. Recently developed lumen‐apposing fully covered self‐expandable metal stents (LAMSs) may facilitate drainage, especially of necrotic and complex PFCs. Objective To evaluate the feasibility and efficacy of a newly developed LAMS (Nagi, Taiwong Medical Co. Ltd, South Korea) in the drainage of PFCs. Methods Retrospective analysis of LAMS drainage of PFCs from seven centres. Patient demographic, EUS and radiological findings, PFCs aetiology, procedural technical and clinical success, and adverse events were evaluated. Results Sixty‐seven patients with mean age 58.8 ± 14 years (68.7% males) were included in the analysis. Of these, 44 patients had pseudocyst (PP) and 23 patients had walled‐off pancreatic necrosis (WOPN). Technical success was achieved in 98.5% of cases and clinical success in 94%. The adverse event rate was 24.2%, higher and mostly due to stent migration and occlusion in the WOPN group as compared to the PP group, despite the time to stent removal being significantly lower in the WOPN group. Conclusions PFC drainage using the Nagi stent is highly feasible and effective, with a relatively safe profile. Future studies enrolling more patients with complex PFCs are needed to clearly establish the role of this stent in PFC management.